These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 24100581)

  • 1. Merging the best of both worlds: hybrid lipid-enveloped matrix nanocomposites in drug delivery.
    Raemdonck K; Braeckmans K; Demeester J; De Smedt SC
    Chem Soc Rev; 2014 Jan; 43(1):444-72. PubMed ID: 24100581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymer-lipid hybrid systems: merging the benefits of polymeric and lipid-based nanocarriers to improve oral drug delivery.
    Rao S; Prestidge CA
    Expert Opin Drug Deliv; 2016; 13(5):691-707. PubMed ID: 26866382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gelation of the internal core of liposomes as a strategy for stabilization and modified drug delivery I. Physico-chemistry study.
    Petralito S; Paolicelli P; Nardoni M; Trilli J; Di Muzio L; Cesa S; Relucenti M; Matassa R; Vitalone A; Adrover A; Casadei MA
    Int J Pharm; 2020 Jul; 585():119467. PubMed ID: 32497730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronidase enzyme core-5-fluorouracil-loaded chitosan-PEG-gelatin polymer nanocomposites as targeted and controlled drug delivery vehicles.
    Rajan M; Raj V; Al-Arfaj AA; Murugan AM
    Int J Pharm; 2013 Sep; 453(2):514-22. PubMed ID: 23796828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled synthesis of uniform and monodisperse upconversion core/mesoporous silica shell nanocomposites for bimodal imaging.
    Liu J; Bu W; Zhang S; Chen F; Xing H; Pan L; Zhou L; Peng W; Shi J
    Chemistry; 2012 Feb; 18(8):2335-41. PubMed ID: 22252972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrogel nanoparticles and nanocomposites for nasal drug/vaccine delivery.
    Salatin S; Barar J; Barzegar-Jalali M; Adibkia K; Milani MA; Jelvehgari M
    Arch Pharm Res; 2016 Sep; 39(9):1181-92. PubMed ID: 27352214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceramic/polymer nanocomposites with tunable drug delivery capability at specific disease sites.
    Liu H; Webster TJ
    J Biomed Mater Res A; 2010 Jun; 93(3):1180-92. PubMed ID: 19777574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid-enveloped hybrid nanoparticles for drug delivery.
    Tan S; Li X; Guo Y; Zhang Z
    Nanoscale; 2013 Feb; 5(3):860-72. PubMed ID: 23292080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supramolecular core-shell nanosilica@liposome nanocapsules for drug delivery.
    Liu M; Gan L; Chen L; Xu Z; Zhu D; Hao Z; Chen L
    Langmuir; 2012 Jul; 28(29):10725-32. PubMed ID: 22746205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug silica nanocomposite: preparation, characterization and skin permeation studies.
    Pilloni M; Ennas G; Casu M; Fadda AM; Frongia F; Marongiu F; Sanna R; Scano A; Valenti D; Sinico C
    Pharm Dev Technol; 2013; 18(3):626-33. PubMed ID: 22324371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxicity of release products from magnetic nanocomposites in targeted drug delivery.
    Wamocha HL; Misak HE; Song Z; Chu HY; Chen YY; Asmatulu R; Yang SY; Ho JC
    J Biomater Appl; 2013 Feb; 27(6):661-7. PubMed ID: 22071353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid conjugated nanoparticles of mixed lipid monolayer shell and biodegradable polymer core for targeted delivery of Docetaxel.
    Liu Y; Li K; Pan J; Liu B; Feng SS
    Biomaterials; 2010 Jan; 31(2):330-8. PubMed ID: 19783040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hybrid Materials and Nanocomposites as Multifunctional Biomaterials.
    Follmann HDM; Naves AF; Araujo RA; Dubovoy V; Huang X; Asefa T; Silva R; Oliveira ON
    Curr Pharm Des; 2017; 23(26):3794-3813. PubMed ID: 28699525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymer encapsulated upconversion nanoparticle/iron oxide nanocomposites for multimodal imaging and magnetic targeted drug delivery.
    Xu H; Cheng L; Wang C; Ma X; Li Y; Liu Z
    Biomaterials; 2011 Dec; 32(35):9364-73. PubMed ID: 21880364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A facile construction strategy of stable lipid nanoparticles for drug delivery using a hydrogel-thickened microemulsion system.
    Chen H; Xiao L; Du D; Mou D; Xu H; Yang X
    Nanotechnology; 2010 Jan; 21(1):015101. PubMed ID: 19946154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid-polymer hybrid nanoparticles as a next-generation drug delivery platform: state of the art, emerging technologies, and perspectives.
    Mukherjee A; Waters AK; Kalyan P; Achrol AS; Kesari S; Yenugonda VM
    Int J Nanomedicine; 2019; 14():1937-1952. PubMed ID: 30936695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery.
    Chan JM; Zhang L; Yuet KP; Liao G; Rhee JW; Langer R; Farokhzad OC
    Biomaterials; 2009 Mar; 30(8):1627-34. PubMed ID: 19111339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of nanocarrier type and size on skin delivery of hydrophilic agents.
    Küchler S; Abdel-Mottaleb M; Lamprecht A; Radowski MR; Haag R; Schäfer-Korting M
    Int J Pharm; 2009 Jul; 377(1-2):169-72. PubMed ID: 19439166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multifunctional upconversion mesoporous silica nanostructures for dual modal imaging and in vivo drug delivery.
    Li C; Yang D; Ma P; Chen Y; Wu Y; Hou Z; Dai Y; Zhao J; Sui C; Lin J
    Small; 2013 Dec; 9(24):4150-9. PubMed ID: 23843254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mixed Hybrid Lipid/Polymer Vesicles as a Novel Membrane Platform.
    Schulz M; Binder WH
    Macromol Rapid Commun; 2015 Dec; 36(23):2031-41. PubMed ID: 26457675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.